肿瘤,高级的临床试验
总计107719个结果
-
Novartis Pharmaceuticals终止
-
Heidelberg Pharma AGUnited States Department of Defense完全的
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)完全的
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City完全的
-
National Cancer Institute (NCI)主动,不招人
-
National Cancer Institute (NCI)主动,不招人造血和淋巴细胞肿瘤 | 晚期淋巴瘤 | 晚期恶性实体瘤 | 难治性淋巴瘤 | 难治性恶性实体瘤美国
-
Nectin Therapeutics LtdMerck Sharp & Dohme LLC招聘中癌症 | 转移癌 | 晚期实体瘤 | 肿瘤,实体 | 局部晚期实体瘤美国, 以色列
-
Takeda完全的癌,晚期 ALK+ 或 ROS1+ 非小细胞肺,肿瘤,晚期 ALK+ 或 ROS1+ 实体瘤西班牙, 意大利, 荷兰, 法国
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.招聘中
-
MediLink Therapeutics (Suzhou) Co., Ltd.Hoffmann-La Roche招聘中
-
University Hospital, Basel, SwitzerlandResearch Center for Clinical Neuroimmunology and Neuroscience Basel尚未招聘
-
Hervor TherapeuticsCancer Institute and Hospital, Chinese Academy of Medical Sciences; Women's Hospital School... 和其他合作者招聘中
-
Latticon Antibody Therapeutics, Inc尚未招聘
-
Eikon TherapeuticsImpact Therapeutics, Inc.招聘中
-
Chengdu JOYO pharma Co., Ltd.Guangzhou JOYO Pharma Co., Ltd尚未招聘